Determination of the Biological Activity of Heparin by Use of a Chromogenic Substrate

Summary

We describe a new method for determining the biological activity of heparin in plasma with use of thrombin and the substrate Tos-Gly-Pro-Arg-pNA. The procedure is based on the photometric determination of the inactivation of thrombin after incubation with plasma in the presence of endogenous antithrombin III (At III). The method allows the specific determination of heparin concentrations from 0.02 USP to 0.8 USP/ml of plasma in the presence of normal At III levels. It has been carried out manually by use of an Eppendorf spectrum line photometer or automatically by use of a Vitatron Akes analyzer. For evaluation, the results were compared with two standard samples which contained heparin in the low and high therapeutic range, respectively.

• References

• 1 Bartl K, Dorsch E, Ziegenhorn J. 1978; Determination of Heparin Using Thrombin and the Substrate Tos-Gly-Pro-Arg-p-nitroanilide. Zeitschrift für Analytische Chemie 290: 102
• 2 Bjoerk I, Nordenman B. 1976; Acceleration of the Reaction between Thrombin and Antithrombin III by Non-stoichiometric Amounts of Heparin. European Journal of Biochemistry 68: 507
• 3 Teien AN, Lie M. 1977; Evaluation of an Amidolytic Heparin Assay Method: Increased Sensitivity by Adding Purified Antithrombin III. Thrombosis Research 10: 399
• 4 Teien AN, Lie M, Abildgaard U. 1976; Assay of Heparin in Plasma Using a Chromogenic Substrate for Activated Factor X. Thrombosis Research 8: 413
• 5 Witt I. 1977; Neue Methoden der Gerinnungsanalysen mit chromogenen Substraten. Journal of Clinical Chemistry and Clinical Biochemistry 15: 239